Certainty right from the start
Join the Certara community of leading experts and scientists in biosimulation, clinical pharmacology, regulatory science, AI/ML, and clinical data science as we explore what’s possible at the Certainty US Annual Conference. Together, we’ll exchange insights, best practices, and proven strategies to bring greater clarity and confidence to every stage of drug discovery and development.
See what awaits you at Certainty
We’ve compiled highlights from our 2026 event in Boston, featuring several thought-provoking discussions and our Certainty Keynote. The sessions touch on the evolution towards model-informed evidence, AI optimization, and the latest innovations helping organizations accelerate decision-making and improve outcomes. Access the on-demand sessions
The Certainty US annual conference showcases how you can reduce risk and achieve success from molecule to market, with certainty right from the start. Our 2026 event in Boston featured six unique tracks designed to address multiple focus areas for attendees, from early discovery to submission.
Our 2027 Certainty program is still in development – join the waitlist to be the first to know when registration opens.
P21 Live: Digital Data Flow Optimization
Follow the flow of data from protocol all the way to submission in this track focused on the Pinnacle 21 technology. We’ll look more closely at P21 capabilities, from mapping specs and APIs to the progress of our solution for metadata management.
Phoenix User Meeting
Phoenix users can explore how empirical PK/PD methods work alongside in silico approaches by attending Modeling & Simulation from Strategy to Approval on Day 1 of Certainty. On Day 2, you’ll get an interactive look at new features, our roadmap, and AI’s expanding role in modeling and reporting.
QSP Summit
Attendees of the QSP Summit are also encouraged to attend Modeling & Simulation from Strategy to Approval on Day 1 of Certainty. On Day 2, we will explore how QSP is transforming MIDD through computational modeling, AI integration, and mechanistic insights. Sessions will feature case studies across disease areas, and forward-looking discussions on regulatory adoption and the future of predictive modeling.
Discovery: Intelligent Lead Optimization with Chemaxon and D360
With the explosion of new modalities, informatics is expanding its scope as AI closes gaps between chemistry, safety, and efficacy. Join this track to explore how predictive modeling is reshaping compound design and enabling a clearer view downstream in drug discovery.
PBPK Modeling Workshop
Attendees of PBPK Modeling Workshop are also encouraged to attend Modeling & Simulation from Strategy to Approval on Day 1 of Certainty. On Day 2, we’ll showcase how PBPK informs decisions for first-in-human dosing to formulation, drug–drug interactions, and special population optimization. Expert talks and case studies will offer practical insights to strengthen confidence in model-informed development.
Modeling and Simulation from Strategy to Approval
Learn how empirical PK/PD methods like NCA and popPK are complementing in silico approaches like PBPK and QSP to answer the most daunting challenges in development, from optimal first-in-human dosing to presenting clin pharm evidence effectively in your NDA or BLA. Attendees of the Phoenix User Meeting, QSP Summit, and PBPK Modeling Workshop are encouraged to attend this session on Day 1 of Certainty.
